Clinician perspectives on preemptive pharmacogenetic testing to guide chemotherapy dosing in patients with gastrointestinal malignancies.

被引:0
|
作者
Lau-Min, Kelsey S. [1 ]
Varughese, Lisa A. [2 ]
Nelson, Maria N. [3 ]
Cambareri, Christine [4 ]
Reddy, Nandi J. [5 ]
Oyer, Randall A. [5 ]
Teitelbaum, Ursina R. [1 ]
Tuteja, Sony [2 ]
机构
[1] Univ Penn, Dept Med, Div Hematol Oncol, Perelman Sch Med, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Med, Div Translat Med & Human Genet, Perelman Sch Med, Philadelphia, PA 19104 USA
[3] Univ Penn, Perelman Sch Med, Dept Family Med & Community Hlth, Mixed Methods Res Lab, Philadelphia, PA 19104 USA
[4] Hosp Univ Penn, Dept Pharm, 3400 Spruce St, Philadelphia, PA 19104 USA
[5] Penn Med Lancaster Gen Hlth, Ann B Barshinger Canc Inst, Lancaster, PA USA
关键词
D O I
10.1200/JCO.2021.39.3_suppl.54
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
54
引用
收藏
页数:3
相关论文
共 50 条
  • [31] Phase Ib trial of pembrolizumab and XL888 in patients with advanced gastrointestinal malignancies.
    Akce, Mehmet
    Alese, Olatunji B.
    Shaib, Walid Labib
    Wu, Christina Sing-Ying
    Lesinski, Gregory B.
    El-Rayes, Bassel F.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [32] Phase I trial of FOLFIRI in combination with sorafenib and bevacizumab in patients with advanced gastrointestinal malignancies.
    Hubbard, Joleen Marie
    Kim, George P.
    Bored, Mitesh J.
    Qin, Rui
    Lensing, Janet
    Wright, John Joseph
    Erlichman, Charles
    Grothey, Axel
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [33] Feasibility of preemptive pharmacogenetic testing and improvement of medication treatment satisfaction among medically underserved patients
    Lteif, Christelle
    Eddy, Elizabeth
    Terrell, Joshua
    Cavallari, Larisa H.
    Malaty, John
    Duarte, Julio D.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (01):
  • [34] Phase I trial of FOLFIRI in combination with sorafenib and bevacizumab in patients with advanced gastrointestinal malignancies.
    Hubbard, Joleen Marie
    Kim, George P.
    Borad, Mitesh J.
    Qin, Rui
    Lensing, Janet
    Wright, John Joseph
    Erlichman, Charles
    Grothey, Axel
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [35] A UGT1A1 genotype-guided dosing study of modified FOLFIRINOX (mFOLFIRINOX) in previously untreated patients (pts) with advanced gastrointestinal malignancies.
    Sharma, Manish
    Catenacci, Daniel V. T.
    Karrison, Theodore
    Ganjoo, Anubha
    Allen, Kenisha
    Suh, Grace K.
    Phillips, Brooke Elizabeth
    Marsh, Robert de Wilton
    Kozloff, Mark
    Polite, Blase N.
    Kindler, Hedy L.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [36] A UGT1AI genotype-guided dosing study of modified FOLFIRINOX (mFOLFIRINOX) in previously untreated patients (pts) with advanced gastrointestinal malignancies.
    Sharma, Manish
    Catenacci, Daniel Virgil Thomas
    Karrison, Theodore
    Allen, Kenisha
    Peterson, Jaclyn D.
    Marsh, Robert de Wilton
    Kozloff, Mark
    Polite, Blase N.
    Kindler, Hedy Lee
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [37] The perspectives of pharmacogenetic testing implementation in patients with suspected primary pulmonary hypertension
    Hromnikova, N.
    Babiak, E.
    Pivackova, L. B.
    Klimas, J.
    Krenek, P.
    Goncalvesova, E.
    Luknar, M.
    Doka, G.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2023, 45 (03) : 796 - 796
  • [38] Which of Algorithms of Warfarin Dosing Based on Results of Pharmacogenetic Testing is Suitable for Patients in Russia?
    Sychev, D. A.
    Antonov, I. M.
    Kropacheva, E. S.
    Panchenko, E. P.
    KARDIOLOGIYA, 2010, 50 (04) : 35 - 37
  • [39] DOSING OF CHEMOTHERAPY IN OBESE ADULT PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES: A SURVEY OF PRACTICE IN THE UK
    Preston, A.
    Duncan, N.
    Robinson, S.
    Braybrooke, J.
    HAEMATOLOGICA, 2016, 101 : 692 - 692
  • [40] Early thermal quantitative sensory testing to measure acute oxaliplatin neurotoxicity and predict chronic neuropathy in gastrointestinal malignancies.
    Reddy, Sangeetha
    Kwon, Nancy
    Nimeiri, Halla Sayed
    Mulcahy, Mary Frances
    Harden, Robert Norm
    Benson, Al Bowen
    Paice, Judith A.
    Vergo, Maxwell Thomas
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)